Veracyte, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
VCYT Nasdaq 3840 www.veracyte.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Veracyte, Inc.

Veracyte (NASDAQ:VCYT) shareholders have earned a 19% return over the last year - Jun 20th, 2025 8:42 am
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound? - Jun 6th, 2025 9:31 am
Veracyte, Inc. (VCYT) Presents Breakthrough Genomic Data to Predict Cancer Therapy Response at ASCO - May 28th, 2025 10:05 pm
Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research - May 28th, 2025 2:05 pm
Veracyte to Participate in Upcoming Investor Conferences - May 20th, 2025 3:00 pm
Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally? - May 19th, 2025 6:38 am
Veracyte, Inc. Just Recorded A 260% EPS Beat: Here's What Analysts Are Forecasting Next - May 10th, 2025 7:19 am
Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up - May 9th, 2025 11:29 am
Veracyte First Quarter 2025 Earnings: Beats Expectations - May 9th, 2025 5:38 am
What Makes Veracyte (VCYT) a New Buy Stock - May 8th, 2025 10:00 am
Veracyte Inc (VCYT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions - May 8th, 2025 1:27 am
Veracyte (VCYT) Q1 Earnings and Revenues Beat Estimates - May 7th, 2025 4:55 pm
Veracyte: Q1 Earnings Snapshot - May 7th, 2025 4:02 pm
Veracyte Announces First Quarter 2025 Financial Results - May 7th, 2025 2:05 pm
Veracyte Stock Earns Relative Strength Rating Upgrade - May 6th, 2025 1:20 pm
Ekso Bionics (EKSO) Reports Q1 Loss, Misses Revenue Estimates - May 5th, 2025 3:35 pm
Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer - Apr 25th, 2025 5:00 am
Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting - Apr 22nd, 2025 7:00 am
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release - Apr 21st, 2025 2:05 pm
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It. - Apr 17th, 2025 2:15 pm